Cancer Targeted Technology

Cancer Targeted Technology is designing and patenting small molecule drugs for cancer with unique diagnostic imaging and therapeutic properties.

diagnostic

CTT1057
PET Imagine Agent for
Prostate Cancer

therapeutic

CTT1403
Radiotherapeutic for
Prostate Cancer

therapeutic

CTT2274
Chemotherapeutic for
Prostate Cancer

Latest News

November 18, 2024

Cancer Targeted Technology Receives Fast Track $2.4M Grant to Develop an Innovative PSMA-Targeted Small Molecule Drug Conjugate for Prostate Cancer

June 29, 2021

Cancer Targeted Technology Receives Milestone Payment for Development of Diagnostic PET Imaging Agent for Prostate Cancer

November 6, 2018

Cancer Targeted Technology Files Investigational New Drug Application for CTT1403, a Novel Radiotherapeutic Drug for Prostate Cancer